NEW DELHIGilead Sciences Inc said Monday it has authorized several generic drug companies in India to sell its aday hepatitis C pill for a fraction of the price in developing countries like Honduras Vietnam and South Africa The Californiabased biotechnology company said it signed licensing deals with seven generic pharmaceutical companies that make drugs in India including Ranbaxy Laboratories Ltd Cipla Ltd and Pennsylvaniabased Mylan Inc to sell generic versions of Sovaldi in  developing countries 